Haemonetics | HAE - Selling And Administration Expenses


Haemonetics reported $109.15M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Avanos Medical USD 77.7M 1.1M Mar/2026
Baxter International USD 728M 33M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Boston Scientific USD 1.78B 53M Mar/2026
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 676.2M 303.1M Mar/2026
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 749M 36M Mar/2026
Globus Medical USD 297.77M 20.7M Mar/2026
Haemonetics USD 109.15M 7.54M Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
Medtronic 2.96B 9M Dec/2025
Merit Medical Systems USD 110.47M 4.36M Mar/2026
Neogen USD 98.5M 9M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Quidel USD 199.3M 4.9M Mar/2026
ResMed USD 279.8M 1.4M Mar/2026
STAAR Surgical USD 38.64M 299K Mar/2026
Steris USD 351.8M 500K Mar/2026
Stryker USD 2.15B 17M Mar/2026
Teleflex USD 226.01M 3.64M Mar/2026
Terumo JPY 114.81B 9.55B Mar/2026
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
US Physical Therapy USD 18.27M 149K Mar/2026
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026